Compare Enveric Biosciences Inc (ENVB) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Vanguard Total Stock Market Index Fund ETF — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while Vanguard Total Stock Market Index Fund ETF trades at $381.48 (market cap $2.30T). The key difference: Vanguard Total Stock Market Index Fund ETF is far larger — about 343796.7× Enveric Biosciences Inc's market cap, and Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Vanguard Total Stock Market Index Fund ETF for 131 Days on average.
| ENVB | VTI | |
|---|---|---|
Market Cap | $6.69M | $2.30T |
Volume | 41,141 | 2,730,571 |
Sector | Health | — |
52-Week High | $10.80 | $384.30 |
52-Week Low | $1.27 | $311.68 |
Typical Hold Time | 14 Days | 131 Days |
Enterprise Value | -$1.60M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
VTI trades at $381.03, down 0.39% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF maintains strong diversification across the U.S. equity market, though key financial ratios are not provided in the snapshot. Recent news highlights long-term growth potential and comparisons with similar funds like VOO.
The outlook for VTI remains positive given broad market exposure and low-cost structure, but risks include concentration in top holdings and market volatility. Analyst sentiment is generally favorable for long-term investors, emphasizing diversification benefits and historical performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
